A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1
William C. Goggins(University Hospital of Lausanne), A. Benedict Cosimi(Massachusetts General Hospital), Anil Chandraker(Brigham and Women's Hospital), Manuel Pascual(University of Lausanne), Dicken S.C. Ko(Harvard University), John A. Powelson(University Hospital of Lausanne), Nina Tolkoff-Rubin(Harvard University), Francis L. Delmonico(Massachusetts Medical Society), Colm Magee(Massachusetts General Hospital), Winfred W. Williams, Mary Lin Farrell, Hugh Auchincloss(Massachusetts General Hospital)
Cited by 244
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
|New England Journal of Medicine|2008|972
Kidney Transplantation as Primary Therapy for End-Stage Renal Disease
|Clinical Journal of the American Society of Nephrology|2008|606
Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys
|Transplantation|1995|555
The promise of organ and tissue preservation to transform medicine
|Nature Biotechnology|2017|530